# Gujarat Themis Biosyn Ltd (GUJTHEM)
> Exchange: NSE | Sector: Pharma | ISIN: INE942C01045

## Price
Current Price: ₹368.7
Day Change: +3.25%
52W High: ₹479
52W Low: ₹225.05
Market Cap: ₹3,793 Cr

## Valuation
P/E: 78.79
P/B: 14.31
EPS: ₹4.41
Book Value: ₹24.28
Dividend Yield: 0%

## Returns
1Y Return: -22.75%

## Profitability
ROE: 0%
ROCE: 24.06%
Debt/Equity: 0.27
Revenue Growth: 9.7%
Profit Growth: -4.2%
EBITDA Margin: 42.93%
Operating Margin: 40.16%

## About
Gujarat Themis Biosyn Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Gujarat Themis Biosyn Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:11.526Z
Price History Updated: 2026-05-18T22:58:42.203Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:42.203Z
Quant Updated: 2026-05-18T22:58:42.203Z
Sentiment Updated: 2026-05-18T22:58:42.203Z
Financials Status: current
Financials Updated: 2026-05-18T13:32:06.966Z
Financials Last Attempt: 2026-05-18T13:32:06.966Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹150.79 Cr
Operating Profit: ₹64.25 Cr (OPM 42.61%)
Net Profit: ₹48.77 Cr
Tax: ₹16.77 Cr

## Annual P&L History
FY25: Rev ₹150.79Cr | PAT ₹48.77Cr | OPM 42.61%
FY24: Rev ₹169.81Cr | PAT ₹59.16Cr | OPM 44.49%
FY23: Rev ₹148.13Cr | PAT ₹57.97Cr | OPM 48.95%

## Balance Sheet (FY25)
Total Assets: ₹301.31 Cr
Total Liabilities: ₹52.93 Cr
Borrowings: ₹30.47 Cr
Cash: ₹11.69 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sachin Dinesh Patel CChem., Ph.D., MD & Director
- Bhavik  Shah, Senior Accounts Manager
- Vineet Ganesh Gawankar, Company Secretary & Compliance Officer
- Krupesh  Patel, Chief Financial Officer
- Do-Seon  Kim, Chief Technical Officer

---
Source: rupiya.io/stocks/gujthem
Disclaimer: For research and education only. Not investment advice.